Home LiteratureArticle Details
PMID: 9796920 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production.

International immunology ·Vol. 10 ·No. 10 ·1998-10-00 ·Pages 1529-38

Tinnell SB, Jacobs-Helber SM, Sterneck E, Sawyer ST, Conrad DH

Abstract

STAT6, NF-kappaB (p50) and C/EBPbeta transcription factors (TF) were examined with respect to CD23 regulation. Electrophoretic mobility shift assay (EMSA), competition and supershift analysis demonstrated that STAT6 binds the CD23a promoter but with a lower affinity than the consensus site. STAT6-/- mice were analyzed for CD23 levels and showed reduced expression after CD40 ligand trimer (CD40LT) stimulation. However, normal CD23 expression and even some IgE production was induced in STAT6-/- mice with CD40LT/IL-4. EMSA analysis indicated that the CD23a STAT site was bound by a protein in nuclear extracts from CD40+/-IL-4-stimulated STAT6-/-B cells. Western blot analysis of these nuclear extracts demonstrated the presence of STAT3 and STAT5, suggesting that these STATs can induce CD23 in this situation. Further supporting evidence was obtained by showing that IL-2 and IL-4 both synergize with CD40 in an identical manner for CD23 induction on STAT6-/- B cells. EMSA analysis of the two putative NF-kappaB sites confirmed binding to both, although one site bound with a higher affinity than the second. Analysis of p50-/-mice indicated that this subunit was not necessary for CD23 induction or CD40/IL-4-induced IgE production. Finally, no role for C/EBP was observed in CD23 induction by EMSA or by CD23 induction analysis in C/EBPbeta-/- mice, whereas the absence of C/EBP, did have an effect on IgE production and lipopolysaccharide-induced B cell proliferation. Based on these data, a model is presented which suggests that CD23 superinduction results from STAT and NF-kappaB interaction.

MeSH Terms
Animals B-Lymphocytes/cytology,immunology,metabolism CCAAT-Enhancer-Binding Proteins CD40 Ligand Cell Nucleus/metabolism Cells, Cultured/drug effects DNA-Binding Proteins/physiology Immunoglobulin E/biosynthesis Interleukin-2/pharmacology Interleukin-4/pharmacology Lymphocyte Activation/drug effects Membrane Glycoproteins/drug effects,metabolism,pharmacology Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Knockout NF-kappa B/physiology Nuclear Proteins/physiology Promoter Regions, Genetic/physiology Receptors, IgE/biosynthesis,drug effects,genetics STAT6 Transcription Factor Trans-Activators/metabolism,physiology
Chemicals
CCAAT-Enhancer-Binding Proteins DNA-Binding Proteins Interleukin-2 Membrane Glycoproteins NF-kappa B Nuclear Proteins Receptors, IgE STAT6 Transcription Factor Stat6 protein, mouse Trans-Activators CD40 Ligand Interleukin-4 Immunoglobulin E
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Tinnell S B
Department of Microbiology and Immunology, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond 23298, USA.
Jacobs-Helber S M
Sterneck E
Sawyer S T
Conrad D H
Article Info
Journal
International immunology
Abbr.
Int Immunol
ISSN
0953-8178
Published
1998-10-00
Pages
1529-38
Language
English
Region
England
NLM ID
8916182
Subset
IM
Grants
NIAID NIH HHS · AI18697 · United States
NIDDK NIH HHS · DK39781 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com